Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	1. Asymptomatic COVID-19 patients. <br/ >2. Patients with known hypersensitivity to glutathione or related drugs. <br/ >3. Patients enrolled in any other investigational drug studies in COVID-19. <br/ >4. Severe infection and need for invasive or non-invasive ventilator support. <br/ >5. Pregnant or lactating women	1. Asymptomatic COVID-19 patients. <br/ >2. Patients with known hypersensitivity to glutathione or related drugs. <br/ >3. Patients enrolled in any other investigational drug studies in COVID-19. <br/ >4. Severe infection and need for invasive or non-invasive ventilator support. <br/ >5. Pregnant or lactating women
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Feb. 27, 2021, 12:45 a.m.	oms	1. Asymptomatic COVID-19 patients. <br/ >2. Patients with known hypersensitivity to glutathione or related drugs. <br/ >3. Patients enrolled in any other investigational drug studies in COVID-19. <br/ >4. Severe infection and need for invasive or non-invasive ventilator support. <br/ >5. Pregnant or lactating women	1. Asymptomatic COVID-19 patients. <br/ >2. Patients with known hypersensitivity to glutathione or related drugs. <br/ >3. Patients enrolled in any other investigational drug studies in COVID-19. <br/ >4. Severe infection and need for invasive or non-invasive ventilator support. <br/ >5. Pregnant or lactating women